AGP Picks
View all

Science & Technology Watch
Provided by AGP

Science & Technology Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on September 22, 2026

Traferox Technologies Inc. Receives FDA Clearance for the X°Port Heart Preservation System
Sep. 22, 2026

Traferox Technologies Inc. Receives FDA Clearance for the X°Port Heart Preservation System

Indeterminate GlobeNewswire
Yuethai Hydraulics Marks 20 Years of Innovation and Reliability
Sep. 22, 2026

Yuethai Hydraulics Marks 20 Years of Innovation and Reliability

Indeterminate GlobeNewswire
365 Data Centers and Megaport Expand Partnership into Nine Additional Markets
Sep. 22, 2026

365 Data Centers and Megaport Expand Partnership into Nine Additional Markets

Indeterminate GlobeNewswire
Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD
Sep. 22, 2026

Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD

Indeterminate GlobeNewswire
Rocket Software Named as a Major Player in IDC MarketScape® for Intelligent Content Services
Sep. 22, 2026

Rocket Software Named as a Major Player in IDC MarketScape® for Intelligent Content Services

Indeterminate GlobeNewswire
Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker
Sep. 22, 2026

Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker

Indeterminate GlobeNewswire
Colorado PPE Opens New Colorado Facility to Deliver Firefighter PPE Care Above and Beyond Standard Compliance
Sep. 22, 2026

Colorado PPE Opens New Colorado Facility to Deliver Firefighter PPE Care Above and Beyond Standard Compliance

Indeterminate GlobeNewswire
Idaho Copper Receives U.S. Forest Service Approval to Commence Drilling at Flagship CuMo Copper-Molybdenum Project
Sep. 22, 2026

Idaho Copper Receives U.S. Forest Service Approval to Commence Drilling at Flagship CuMo Copper-Molybdenum Project

Indeterminate GlobeNewswire
Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015
Sep. 22, 2026

Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015

Indeterminate GlobeNewswire
Other World Computing (OWC) Wins Tech & Learning Awards of Excellence: Back to School 2026!
Sep. 22, 2026

Other World Computing (OWC) Wins Tech & Learning Awards of Excellence: Back to School 2026!

Indeterminate GlobeNewswire
Marchex Expands Investor Relations Program, Engages PondelWilkinson to Broaden Investor Outreach
Sep. 22, 2026

Marchex Expands Investor Relations Program, Engages PondelWilkinson to Broaden Investor Outreach

Indeterminate GlobeNewswire
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
Sep. 22, 2026

Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome

Indeterminate GlobeNewswire
Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
Sep. 22, 2026

Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Indeterminate GlobeNewswire
Caseware Named as Finalist in Three Categories at the 2026 A.I. Awards
Sep. 22, 2026

Caseware Named as Finalist in Three Categories at the 2026 A.I. Awards

Indeterminate GlobeNewswire
Elevar Therapeutics Receives FDA Conditional Acceptance of LYRFIGTU as Brand Name for Lirafugratinib
Sep. 22, 2026

Elevar Therapeutics Receives FDA Conditional Acceptance of LYRFIGTU as Brand Name for Lirafugratinib

Indeterminate GlobeNewswire
Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria
Sep. 22, 2026

Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria

Indeterminate GlobeNewswire
Zeo Energy Enters Cooperation Agreement with Ewyze to Develop Integrated Off-Grid Power and Data-Center Infrastructure
Sep. 22, 2026

Zeo Energy Enters Cooperation Agreement with Ewyze to Develop Integrated Off-Grid Power and Data-Center Infrastructure

Indeterminate GlobeNewswire
Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium
Sep. 22, 2026

Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium

Indeterminate GlobeNewswire
Funnel enters a new era as multifamily’s first front-office-only AI platform
Sep. 22, 2026

Funnel enters a new era as multifamily’s first front-office-only AI platform

Indeterminate GlobeNewswire
New Phocas State of Sales in Distribution 2026 Report reveals AI use is growing but key sales metrics go untracked
Sep. 22, 2026

New Phocas State of Sales in Distribution 2026 Report reveals AI use is growing but key sales metrics go untracked

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science & Technology Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.